Sunday, May 16, 2021 | Last Update : 06:08 PM IST

Remdesivir

Differential vaccine pricing is right, Centre tells Supreme Court

Government defends move, says it is to incentivise vaccine makers

11 May 2021 7:54 AM

Top Remdesivir supplier grilled in Mumbai as MVA & BJP tussle

Furious BJP leaders have accused the Maharashtra state government of harassing the Remdesivir suppliers in the state

19 Apr 2021 12:39 AM

India gives 3,000 vials of Remdesivir to 'friendly' Myanmar to help fight COVID-19

General Naravane and Shringla's two-day visit to Myanmar assumes significance as it comes in the midst of the India-China standoff

05 Oct 2020 3:23 PM

US hospitals turn down remdesivir, limit use to severely ill since July

The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir

12 Sep 2020 1:10 PM

Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said

09 Sep 2020 12:21 PM

ADVERTISEMENT

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Maharashtra FDA to buy remdesivir from Gujarat firm

State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency

26 Jul 2020 3:55 PM

Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir

On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions

21 Jul 2020 10:01 AM

Seven held for selling Remdesivir injections at higher cost

The officials said that each vial of the injection was being sold at 30,000 instead of 4,500

20 Jul 2020 12:50 PM

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines

09 Jul 2020 9:10 AM

ADVERTISEMENT

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

05 Jul 2020 1:54 PM

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir

Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila

14 Jun 2020 9:59 AM

ADVERTISEMENT

Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma

13 Jun 2020 11:35 PM

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak

03 Jun 2020 11:57 AM

Despite FDA warning, Trump says he is taking hydroxychloroquine

The Food and Drug Administration has issued a warning about its use

19 May 2020 10:15 AM

Health groups want India to rescind Gilead drug patents

Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.

15 May 2020 11:46 AM

Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19

13 May 2020 8:44 AM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT